1 Receptor subtype is involved in the relief of behavioral despair in the mouse forced swimming test

European Journal of Pharmacology

Volumn 312, Issue 3, 1996, Pages 267-271

  Matsuno, Kiyoshi ^a   Kobayashi, Tetsuya ^a   Tanaka, Mihoko K ^a   Mita, Shiro ^a  

^a SANTEN PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1 Receptor agonist; Antidepressive effect; Forced swimming test; Mouse; SA4503

Indexed keywords

1 (3,4 DIMETHOXYPHENETHYL) 4 (3 PHENYLPROPYL)PIPERAZINE; 1,3 BIS(2 METHYLPHENYL)GUANIDINE; 2 [4 METHOXY 3 (2 PHENYLETHOXY)PHENYL] N,N DIPROPYLETHYLAMINE; IGMESINE; MIANSERIN; OPIATE AGONIST; PENTAZOCINE; RECEPTOR SUBTYPE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; 1,3 DITOLYLGUANIDINE; 1,3-DITOLYLGUANIDINE; ANISOLE DERIVATIVE; CINNAMIC ACID DERIVATIVE; CYCLOPROPANE DERIVATIVE; GUANIDINE DERIVATIVE; N,N DIPROPYL 2 (4 METHOXY 3 (2 PHENYLETHOXY)PHENYL)ETHYLAMINE MONOHYDROCHLORIDE; N,N-DIPROPYL-2-(4-METHOXY-3-(2-PHENYLETHOXY)PHENYL)ETHYLAMINE MONOHYDROCHLORIDE; PIPERAZINE DERIVATIVE; PROPYLAMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEPRESSION; DRUG RECEPTOR BINDING; FORCED SWIMMING TEST; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MOTOR ACTIVITY; MOUSE STRAIN; STRESS;

ANIMALS; ANISOLES; CINNAMATES; CYCLOPROPANES; GUANIDINES; MALE; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; PENTAZOCINE; PIPERAZINES; PROPYLAMINES; RECEPTORS, SIGMA; STRESS;

EID: 0030567874     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00497-9     Document Type: Article

References (28)

1. Beart, P.M., R.D. O'Shea and D.T. Manallack, 1989, Regulation of σ-receptors: high-and low-affinity agonist states. GTP shifts, and upregulation by rimcazole and 1.3-di(2-tolyl)guanidine, J. Neurochem. 53, 779.
2. Bunney, W.E. and J.M. Davies, 1965, Norepinephrine in depressive reactions, Arch. Gen. Psychiat. 13, 483.
3. 1 binding sites in guinea pig brain, Eur. J. Pharmacol. 251, R1.
4. Connick, J.H., G. Hanlon, J. Roberts, L. France, P.K. Fox and C.D. Nicholson, 1992, Multiple σ binding sites in guinea-pig and rat brain membranes: G-protein interactions, Br. J. Pharmacol. 107, 726.
5. Ellis, Y. and J.A. Davies, 1994, The effects of sigma ligands on the release of glutamate from rat striatal slices, Naunyn-Schmiedeberg's Arch. Pharmacol. 350, 143.
6. Fletcher, E.J., J. Church, K. Adbel-Hamid and J.F. MacDonald, 1993, Selective reduction of N-methyl-D-aspartate-evoked responses by 1,3-di(2-tolyl)guanidine in mouse and rat cultured hippocampal pyramidal neurons, Br. J. Pharmacol. 109, 1196.
7. Itzhak, Y., 1994, Multiple sigma binding sites in the brain, in: Sigma Receptors, ed. Y. Itzhak (Academic Press, San Diego) p. 113.
8. Itzhak, Y. and C.O. Kassim, 1990, Clorgyline displays high affinity for σ binding sites in C57BL/6 mouse brain, Eur. J. Pharmacol. 176, 107.
9. Itzhak, Y. and M. Khouri, 1988, Regulation of the binding of σ-and phencyclidine (PCP)-receptor ligands in rat brain membranes by guanine nucleotides and ions, Neurosci. Lett. 85, 147.
10. Itzhak, Y. and I. Stein, 1991, Regulation of σ receptors and responsiveness to guanine nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple σ binding sites, Brain Res. 566, 166.
11. 3H]acetylcholine release from rat hippocampal slices, Eur. J. Pharmacol. 200, 343.
12. Kinouchi, K., S. Maeda, K. Saito, R. Inoki, K. Fukumitsu and I. Yoshiya, 1989, Effects of D-and L-pentazocine on the release and uptake of norepinephrine in rat brain cortex, Res. Commun. Chem. Path. Pharmacol. 63, 201.
13. Matsuno, K., K. Matsunaga, T. Senda and S. Mita, 1993, Increase in extracellular acetylcholine level by sigma ligands in rat frontal cortex, J. Pharmacol. Exp. Ther. 265, 851.
14. Matsuno, K., T. Senda, K. Matsunaga and S. Mita, 1994, Ameliorating effects of σ receptor ligands on the impairment of passive avoidance tasks in mice: involvement in the central acetylcholinergic system, Eur. J. Pharmacol. 261, 43.
15. Matsuno, K., K.H. Matsunaga and S. Mita, 1995a, Acute effects of σ ligands on the extracellular DOPAC level in rat frontal cortex and striatum, Neurochem. Res. 20, 233.
16. 1 receptor in (+)-N-allylnormetazocine-stimulated hippocampal cholinergic functions in rats, Brain Res. 690, 200.
17. 1 receptor agonist, Eur. J. Pharmacol. 306, 271.
18. 1 receptor agonistic properties, Behas. Brain Res. (in press).
19. 3H]noradrenaline release in the rat hippocampus: G-protein dependency, Naunyn-Schmiedeberg's Arch. Pharmacol. 346, 32.
20. Okuyama, S., Y. Imagawa, S. Ogawa, H. Araki, A. Ajima, M. Tanaka, M. Muramatsu, A. Nakazato, K. Yamaguchi, M. Yoshida and S. Otomo, 1993, NE-100, a novel sigma receptor ligand: in vivo tests, Life Sci. 53, PL285.
21. Porsolt, R.D., A. Bertin and M. Jalfre, 1977a, Behavioral despair in mice: a primary screening test for antidepressants, Arch. Int. Pharmacodyn. 229, 327.
22. Porsolt, R.D., M. Le Pichon and M. Jalfre, 1977b, Depression: a new animal model sensitive to antidepressant treatments, Nature (London) 266, 730.
23. Quirion, R., W.D. Bowen, Y. Itzhak, J.L. Junien, J.M. Musacchio, R.B. Rothman, T.-P. Su, S.W. Tam and D.P. Taylor, 1992, A proposal for the classification of sigma binding sites, Trends Pharmacol. Sci. 13, 85.
24. 3H]-noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells, Br. J. Pharmacol. 103, 1917.
25. Roman, F.J., X. Pascaud, B. Martin, D. Vauché and J.-L. Junien, 1990, JO 1784, a potent and selective ligand for rat and mouse brain σ-sites, J. Pharm. Pharmacol. 42, 439.
26. 3H]3-PPP binding to σ sites in rat brain, Eur. J. Pharmacol. 165, 335.
27. 3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes, Naunyn-Schmiedeberg's Arch. Pharmacol. 351, 244.
28. Trullas, R. and P. Skolnick, 1990, Functional antagonists at the NMDA receptor channel exhibit antidepressant actions, Eur. J. Pharmacol. 185, 1.